NeuroBo Pharmaceuticals, Inc. NRBO
2.36 +2.36
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2023 · select a line to chart its full history
Income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -15.89M | -19.63M | -15.30M | -29.72M | -20.18M | |
| -12.47M | -13.97M | -15.28M | -29.68M | -21.31M | |
| -2.46 | -43.42 | -158.48 | -439.24 | -979.30 |
Balance sheet
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 22.43M | 33.36M | 16.39M | 10.09M | 13.92M | |
| 22.78M | 33.53M | 16.80M | 10.97M | 14.47M | |
| 6.10M | 11.78M | 2.20M | 3.77M | 2.18M | |
| 203.00K | 0 | 71.00K | 94.00K | 116.00K | |
| 16.68M | 21.75M | 14.60M | 7.20M | 12.29M |
Cash flow
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| -10.80M | -11.71M | -15.13M | -10.76M | -7.04M | |
| -50.00K | 8.00K | -586.00K | 69.00K | -6.06M | |
| -80.00K | 28.68M | 22.03M | 6.86M | 24.17M | |
| -50.00K | 8.00K | -3.00K | -4.00K | -214.00K | |
| -10.93M | 16.98M | 6.31M | -3.84M | 11.07M |